PRODUCT NAME
NOROCLAV 100 ML INJ
Composition:
Noroclav Inj. is a yellowish-white suspension containing:
-Amoxicillin 140 mg/ml as amoxicillin trihydrate Ph.Eur. in combination with
-Clavulanic acid 35 mg/ml as clavulanate potassium in an oily base.
Indications:
Noroclav Inj. has a broad spectrum of bactericidal action against bacteria generally found in cattle, dogs and cats.
(a) In vitro, Noroclav Inj. is active against a wide range of clinically important bacteria, as follows:
Gram-positive: Staphylococci (including beta-lactamase producers), Streptococci, Corynebacteria, Clostridia, Bacillus anthracis, Actinomyces bovis. Gram-negative: Escherichia coli (including beta-lactamase-producing ones), Salmonella spp. (including beta-lactamase-producing ones), Campylobacter spp., Klebsiella spp., Proteus spp., Pasteurella spp., Fuso-bacterium necrophorum, Bacteroides spp. (including
beta-lactamase-producing bodies)
Target species:
Cattle and dogs and cats.
Dosage and method of administration:
Administer as intramuscular injections at a dose of 8.75 mg/kg bw (1 ml/20 kg bw) daily for 3 to 5 days. Shake well before use. After administration, gently massage the injection site. Clavulanic acid is very sensitive to moisture, so always use sterile and completely dry syringes and needles. The suspension is not indicated for intrarectal intravenous administration.